EXPOSURE VIA EYE CONTACT

This adverse event was reported 421 times

These drugs are most commonly taken by patients reporting EXPOSURE VIA EYE CONTACT:

# Drug Count
0 DUPILUMAB 47
1 TREPROSTINIL 27
2 FLUTICASONE PROPIONATE 26
3 ALBUTEROL SULFATE 19
4 SOMATROPIN 14
5 MINOXIDIL 11
6 MINOXIDIL FOAM 5% (WOMENS) 11
7 ADALIMUMAB 10
8 CRISABOROLE 9
9 ERGOCALCIFEROL 9
See all common drugs associated with EXPOSURE VIA EYE CONTACT

EXPOSURE VIA EYE CONTACT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 3 0.0044
1 Skin Test Antigen [EPC] 6 0.0032
2 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 5 0.0028
3 Pyrethroid [EPC] 1 0.0006
4 Endoglycosidase [EPC] 1 0.0005
5 Sulfonamide Antibacterial [EPC] 2 0.0005
6 PCSK9 Inhibitor [EPC] 9 0.0003
7 Plasma Volume Expander [EPC] 1 0.0003
8 Provitamin D2 Compound [EPC] 9 0.0003
9 Antiparasitic [EPC] 1 0.0002
See all drug classes enriched for association with EXPOSURE VIA EYE CONTACT